Yousif Capital Management
TAK icon

Yousif Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Yousif Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,394
Closed -$600K – 1762
2026
Q1 		$600K Hold
32,394
– – 0.01% 1312
2025
Q4 		$523K Hold
32,394
– – 0.01% 1397
2025
Q3 		$474K Hold
32,394
– – 0.01% 1459
2025
Q2 		$501K Buy
32,394
+2,525
+8% +$37.3K 0.01% 1454
2025
Q1 		$444K Sell
29,869
-18,250
-38% -$256K 0.01% 1489
2024
Q4 		$637K Sell
48,119
-792
-2% -$10.9K 0.01% 1378
2024
Q3 		$696K Sell
48,911
-3,186
-6% -$45.2K 0.01% 1352
2024
Q2 		$674K Hold
52,097
– – 0.01% 1334
2024
Q1 		$724K Buy
52,097
+400
+0.8% +$5.82K 0.01% 1350
2023
Q4 		$738K Hold
51,697
– – 0.01% 1370
2023
Q3 		$800K Sell
51,697
-1,810
-3% -$28K 0.01% 1252
2023
Q2 		$841K Buy
53,507
+392
+0.7% +$6.42K 0.01% 1242
2023
Q1 		$875K Buy
53,115
+220
+0.4% +$3.5K 0.01% 1210
2022
Q4 		$825K Hold
52,895
– – 0.01% 1273
2022
Q3 		$686K Buy
52,895
+4,230
+9% +$58.8K 0.01% 1376
2022
Q2 		$683K Sell
48,665
-345
-0.7% -$4.92K 0.01% 1425
2022
Q1 		$702K Hold
49,010
– – 0.01% 1498
2021
Q4 		$668K Buy
+49,010
New +$687K 0.01% 1552

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Yousif Capital Management's TAK Position: Q2 2026 in Review

Yousif Capital Management sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 32,394 shares — an estimated $600K sold.

Yousif Capital Management first reported a position in TAK in Q4 2021 and held it in 18 quarters. The position peaked at $875K in Q1 2023. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Yousif Capital Management reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Yousif Capital Management sold 32,394 Takeda Pharmaceutical shares in Q2 2026, an estimated $600K.
  • Yousif Capital Management first reported a position in Takeda Pharmaceutical in Q4 2021 and held it in 18 quarters.
  • Yousif Capital Management's Takeda Pharmaceutical position peaked at $875K in Q1 2023.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.